Modulation of Tumor Tolerance in Primary Central Nervous System Malignancies
Abstract
Central nervous system tumors take advantage of the unique immunology of the CNS and develop exquisitely complex stromal networks that promote growth despite the presence of antigen-presenting cells and tumor-infiltrating lymphocytes. It is precisely this immunological paradox that is essential to the survival of the tumor. We review the evidence for functional CNS immune privilege and the impact it has on tumor tolerance. In this paper, we place an emphasis on the role of tumor-infiltrating myeloid cells in maintaining stromal and vascular quiescence, and we underscore the importance of indoleamine 2,3-dioxygenase activity as a myeloid-driven tumor tolerance mechanism. Much remains to be discovered regarding the tolerogenic mechanisms by which CNS tumors avoid immune clearance. Thus, it is an open question whether tumor tolerance in the brain is fundamentally different from that of peripheral sites of tumorigenesis or whether it simply stands as a particularly strong example of such tolerance.Citation
Clin Dev Immunol. 2012 Jan 24; 2012:937253ae974a485f413a2113503eed53cd6c53
10.1155/2012/937253
Scopus Count
Related articles
- T-cell receptor V-gene usage in neoplasms of the central nervous system. A comparative analysis in cultured tumor infiltrating and peripheral blood T cells.
- Authors: Merlo A, Filgueira L, Zuber M, Juretic A, Harder F, Gratzl O, De Libero G, Heberer M, Spagnoli GC
- Issue date: 1993 Apr
- Myeloid cell heterogeneity in the tumor microenvironment and therapeutic implications for childhood central nervous system (CNS) tumors.
- Authors: Kalathoor S, Rajendran S, Canella A, Raval R, Cripe TP, Mardis ER, Rajappa P
- Issue date: 2023 Jan 15
- The role of microglia in central nervous system immunity and glioma immunology.
- Authors: Yang I, Han SJ, Kaur G, Crane C, Parsa AT
- Issue date: 2010 Jan
- Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination.
- Authors: Jackson CM, Kochel CM, Nirschl CJ, Durham NM, Ruzevick J, Alme A, Francica BJ, Elias J, Daniels A, Dubensky TW Jr, Lauer P, Brockstedt DG, Baxi EG, Calabresi PA, Taube JM, Pardo CA, Brem H, Pardoll DM, Lim M, Drake CG
- Issue date: 2016 Mar 1
- Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways.
- Authors: Weller RO, Engelhardt B, Phillips MJ
- Issue date: 1996 Jul